Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Downgrades IBEX to Neutral, Announces $17 Price Target

Author: Benzinga Newsdesk | November 10, 2023 05:44am
Piper Sandler analyst Arvind Ramnani downgrades IBEX (NASDAQ:IBEX) from Overweight to Neutral and announces $17 price target.

Posted In: IBEX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist